Fantastic results and clearly explained. I’m on the waiting list here in the UK for Mavacamten, as it recently received the green light from NICE. While I am tampering my expectations, all the results from the different trials are most encouraging. This is a remarkable step forward for the treatment of hypertrophic cardiomyopathy and all the scientists and clinicians involved should be congratulated.

Mavacamten is the first drug for HOCM and is a game-changer.

Dr Radar is “one of the good ones”. Not all cardiologists are created equal!!